glutathione mutations in sclc patients Oncology Letters Frontiers | Metabolic reprogramming in
Frontiers Metabolic reprogramming in lung cancer and its clinical implication Unveiling the powerhouse: ASCL1 driven small cell lung cancer is characterized by higher numbers of mitochondria and enhanced oxidative phosphorylation Cancer & Metabolism Springer Nature Link Glutathione Depletion and Stalwart Anticancer Activity of Metallotherapeutics Inducing Programmed Cell Death: Opening a New Window for Cancer Therapy ACS Omega Frontiers Broadening horizons: research on ferroptosis in lung cancer and its potential therapeutic targets
Pay in 4 interest-free payments of $7.13 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18



